Discover
THE MORNING BRIEF
South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection
Update: 2025-10-29
Share
Description
South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection.
Guest: Prof. Glenda Gray - Director of the Infectious Disease and Oncology Research Institute (IDORI) at Wits University
Comments
In Channel
00:00
00:00
x
0.5x
0.8x
1.0x
1.25x
1.5x
2.0x
3.0x
Sleep Timer
Off
End of Episode
5 Minutes
10 Minutes
15 Minutes
30 Minutes
45 Minutes
60 Minutes
120 Minutes



